Multiple Doses of Cnty-101, an iPSC-Derived Allogeneic CD19 Targeting CAR-NK Product, Are Safe and Result in Tumor Microenvironment Changes Associated with Response: A Case Study

被引：7

作者：

Ramachandran, Indu ^{[1
]}

Rothman, Sarah ^{[1
]}

Clausi, Mariano ^{[1
]}

Mcfadden, Kile ^{[1
]}

Salantes, Brenda ^{[1
]}

Jih, Gloria ^{[1
]}

Brigman, Thomas ^{[1
]}

Kelly, Sam ^{[1
]}

Hall, Matthew S. ^{[1
]}

Yee, Stephanie ^{[1
]}

Koumenis, Iphigenia ^{[1
]}

Das, Poulomee ^{[1
]}

Briggs, Jordan ^{[2
]}

Braun, Tori ^{[2
]}

Yuan, Ying ^{[3
]}

Devlin, Elizabeth ^{[1
]}

Farid, Adrienne ^{[1
]}

Trede, Nikolaus S. ^{[1
]}

Moyo, Tamara K. ^{[4
]}

Latif, Tahir ^{[5
]}

Patel, Krish ^{[2
]}

机构：

[1] Century Therapeut, Philadelphia, PA USA

[2] Swedish Canc Inst, Seattle, WA USA

[3] Univ Texas MD Anderson Canc Ctr, Houston, TX USA

[4] Atrium Hlth, Levine Canc Inst, Charlotte, NC USA

[5] Univ Cincinnati, Med Ctr, Cincinnati, OH USA

来源：

关键词：

D O I：

10.1182/blood-2023-182313

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：4

共 3 条